Literature DB >> 26697839

MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis.

Fujun Yu1, Zhongqiu Lu2, Jing Cai3, Kate Huang4, Bicheng Chen5, Guojun Li6, Peihong Dong1, Jianjian Zheng5.   

Abstract

Emerging evidence shows that Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) plays a pivotal role in cell proliferation, migration, and invasion in tumors. However, the biological role and underlying mechanism of MALAT1 in liver fibrosis remains undefined. In this study, up-regulation of MALAT1 was observed in fibrotic liver tissues and in activated hepatic stellate cells (HSCs). In addition, depletion of MALAT1 inhibited the activation of HSCs in vitro and attenuated collagen deposits in vivo. Our results demonstrated that MALAT1 expression is negatively correlated with microRNA-101b (miR-101b) expression. Furthermore, there was a negative feedback loop between the levels of MALAT1 and miR-101b. Luciferase reporter assay indicated that MALAT1 and RAS-related C3 botulinum substrate 1 (Rac1) are targets of miR-101b. We uncovered that MALAT1 regulates Rac1 expression through miR-101b as a competing endogenous RNA (ceRNA), thereby influencing the proliferation, cell cycle and activation of primary HSCs. Collectively, The ceRNA regulatory network may prompt a better understanding of liver fibrogenesis and contribute to a novel therapeutic strategy for liver fibrosis.

Entities:  

Keywords:  Competing endogenous RNA; Liver fibrosis; Long non-coding RNA; Metastasis-associated lung adenocarcinoma transcript 1; MicroRNA-101b

Mesh:

Substances:

Year:  2015        PMID: 26697839      PMCID: PMC4825734          DOI: 10.1080/15384101.2015.1120917

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  45 in total

1.  A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes.

Authors:  Kevin C Miranda; Tien Huynh; Yvonne Tay; Yen-Sin Ang; Wai-Leong Tam; Andrew M Thomson; Bing Lim; Isidore Rigoutsos
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

2.  Epigenetic deregulated miR-375 contributes to the constitutive activation of JAK2/STAT signaling in myeloproliferative neoplasm.

Authors:  Li-hui Yin; Xiao-qun Zheng; Hai-ying Li; Lai-xi Bi; Yi-fen Shi; Ai-fang Ye; Jian-bo Wu; Shen-meng Gao
Journal:  Leuk Res       Date:  2015-01-28       Impact factor: 3.156

3.  Activation of Rac1 promotes hedgehog-mediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cells.

Authors:  Steve S Choi; Rafal P Witek; Liu Yang; Alessia Omenetti; Wing-Kin Syn; Cynthia A Moylan; Youngmi Jung; Gamze F Karaca; Vanessa S Teaberry; Thiago A Pereira; Jiangbo Wang; Xiu-Rong Ren; Anna Mae Diehl
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

4.  Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice.

Authors:  Steve S Choi; Jason K Sicklick; Qi Ma; Liu Yang; Jiawen Huang; Yi Qi; Wei Chen; Yin-Xiong Li; Pascal J Goldschmidt-Clermont; Anna Mae Diehl
Journal:  Hepatology       Date:  2006-11       Impact factor: 17.425

5.  MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.

Authors:  Yongqiang Dong; Guojun Liang; Bo Yuan; Chaoqun Yang; Rui Gao; Xuhui Zhou
Journal:  Tumour Biol       Date:  2014-11-28

6.  Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells.

Authors:  Xinyu Wang; Meng Li; Zhiqiong Wang; Sichong Han; Xiaohu Tang; Yunxia Ge; Liqing Zhou; Changchun Zhou; Qipeng Yuan; Ming Yang
Journal:  J Biol Chem       Date:  2014-12-23       Impact factor: 5.157

7.  Association study of genetic variations in microRNAs with the risk of hepatitis B-related liver diseases.

Authors:  Joon Seol Bae; Jeong-Hyun Kim; Charisse Flerida A Pasaje; Hyun Sub Cheong; Tae Hoon Lee; In Song Koh; Hyo-Suk Lee; Yoon Jun Kim; Hyoung Doo Shin
Journal:  Dig Liver Dis       Date:  2012-05-30       Impact factor: 4.088

8.  WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.

Authors:  I Vassallo; P Zinn; M Lai; P Rajakannu; M-F Hamou; M E Hegi
Journal:  Oncogene       Date:  2015-03-16       Impact factor: 9.867

9.  Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.

Authors:  Hiroshi Hirata; Yuji Hinoda; Varahram Shahryari; Guoren Deng; Koichi Nakajima; Z Laura Tabatabai; Nobuhisa Ishii; Rajvir Dahiya
Journal:  Cancer Res       Date:  2015-01-19       Impact factor: 12.701

10.  A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA.

Authors:  Marcella Cesana; Davide Cacchiarelli; Ivano Legnini; Tiziana Santini; Olga Sthandier; Mauro Chinappi; Anna Tramontano; Irene Bozzoni
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

View more
  40 in total

1.  Long Non-coding RNA in Liver Metabolism and Disease: Current Status.

Authors:  Yulan Zhao; Jianguo Wu; Suthat Liangpunsakul; Li Wang
Journal:  Liver Res       Date:  2017-12-02

Review 2.  Long Noncoding RNAs and Human Liver Disease.

Authors:  Johanna K DiStefano; Glenn S Gerhard
Journal:  Annu Rev Pathol       Date:  2021-08-20       Impact factor: 32.350

3.  NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6.

Authors:  Fujun Yu; Zhe Jiang; Bicheng Chen; Peihong Dong; Jianjian Zheng
Journal:  J Mol Med (Berl)       Date:  2017-09-01       Impact factor: 4.599

4.  Overexpression of lincRNA02471 promote cancer development though miR-758/HIPK3 signaling pathway in papillary thyroid cancer.

Authors:  Lili Ji; Wenying Chen; Xing Fan; Feng Zhou; Xuedong Deng; Jun Gu
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

5.  Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells.

Authors:  Fatjon Leti; Christophe Legendre; Christopher D Still; Xin Chu; Anthony Petrick; Glenn S Gerhard; Johanna K DiStefano
Journal:  Transl Res       Date:  2017-09-19       Impact factor: 7.012

6.  LncRNA Neat1 expedites the progression of liver fibrosis in mice through targeting miR-148a-3p and miR-22-3p to upregulate Cyth3.

Authors:  Wei Huang; Feizhou Huang; Rui Zhang; Hongwu Luo
Journal:  Cell Cycle       Date:  2021-02-08       Impact factor: 4.534

Review 7.  Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn's Disease: The Path From Bench to Bedside.

Authors:  Long-Yuan Zhou; Si-Nan Lin; Florian Rieder; Min-Hu Chen; Sheng-Hong Zhang; Ren Mao
Journal:  Inflamm Bowel Dis       Date:  2021-06-15       Impact factor: 7.290

Review 8.  Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets.

Authors:  B Alipoor; S Nikouei; F Rezaeinejad; S-N Malakooti-Dehkordi; Z Sabati; H Ghasemi
Journal:  J Endocrinol Invest       Date:  2021-04-01       Impact factor: 4.256

9.  Association of MALAT1 and PVT1 Variants, Expression Profiles and Target miRNA-101 and miRNA-186 with Colorectal Cancer: Correlation with Epithelial-Mesenchymal Transition.

Authors:  Abdullah F Radwan; Olfat G Shaker; Noha A El-Boghdady; Mahmoud A Senousy
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

10.  Identification of a Novel lincRNA-p21-miR-181b-PTEN Signaling Cascade in Liver Fibrosis.

Authors:  Fujun Yu; Zhongqiu Lu; Bicheng Chen; Peihong Dong; Jianjian Zheng
Journal:  Mediators Inflamm       Date:  2016-08-16       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.